STAT Plus: Sanofi suffers setback as panel recommends against dengue vaccine in adults
BULLIT MARQUEZ/AP
Dengvaxia is the first dengue vaccine to make it to market anywhere in the world. But it has been accompanied by enormous problems.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario